Profil

Bonnet Christophe

GIGA I3 - Hematology

See author's contact details
Main Referenced Co-authors
Beguin, Yves  (35)
Fillet, Georges  (30)
De Prijck, Bernard  (22)
Baron, Frédéric  (20)
Willems, Evelyne  (19)
Main Referenced Keywords
Humans (10); Female (6); Male (6); Middle Aged (6); Hematology (5);
Main Referenced Disciplines
Hematology (94)
Oncology (2)
Cardiovascular & respiratory systems (1)
Dermatology (1)
Gastroenterology & hepatology (1)

Publications (total 101)

The most downloaded
10875 downloads
Jaspers, A., Baron, F., Bonnet, C., De Prijck, B., Fassotte, M.-F., & Beguin, Y. (2010). Le lymphome du manteau. Revue Médicale de Liège, 65, 171-176. https://hdl.handle.net/2268/80188

The most cited

297 citations (Scopus®)

Récher, C., Coiffier, B., Haioun, C., Molina, T. J., Fermé, C., Casasnovas, O., Thièblement, C., Bosly, A., Laurent, G., Morschhauser, F., Ghesquières, H., Jardin, F., Bologna, S., Fruchart, C., Corront, B., Gabarre, J., Bonnet, C., Janvier, M., Canioni, D., ... Tilly, H. (2011). Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial. The Lancet, 378(9806), 1858-1867. doi:10.1016/S0140-6736(11)61040-4 https://hdl.handle.net/2268/144379

Douven, U., Janssens, A., Crochet, G., Bailly, S., Bonnet, C., Jacquy, C., Offner, F., Snauwaert, S., Van den Neste, E., Vercruyssen, M., Dierickx, D., Vandenberghe, P., & Vergote, V. (June 2023). BHS GUIDELINES ON THE MANAGEMENT OF RELAPSED AND REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: PART 2. Belgian Journal of Hematology, 14, 170-177.
Peer Reviewed verified by ORBi

Douven, U., Janssens, A., Crochet, G., Bailly, S., Bonnet, C., Jacquy, C., Offner, F., Snauwaert, S., Van Den Neste, E., Vercruyssen, M., Dierickx, D., Vandenberghe, P., & Vergote, V. (May 2023). BHS guidelines on the management of relapsed and refractory diffuse large B-cell lymphoma: Part 1. Belgian Journal of Hematology, 14, 114-121.
Peer Reviewed verified by ORBi

Aubrais, R., Bouabdallah, K., Chartier, L., Herbaux, C., Banos, A., Brice, P., Sibon, D., Schiano, J. M., Cluzeau, T., Laribi, K., LE Calloch, R., Bellal, M., Delapierre, B., Daguindau, N., Amorim, S., Agbetiafa, K., Chauchet, A., Besson, C., Durot, E., ... Parrens, M.-C. (2023). Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA. Blood Advances. doi:10.1182/bloodadvances.2022008524
Peer Reviewed verified by ORBi

Veloza, L., Cavalieri, D., Missiaglia, E., Ledoux-Pilon, A., Bisig, B., Pereira, B., Bonnet, C., Poullot, E., Quintanilla-Martinez, L., Dubois, R., Llamas-Gutierrez, F., Bossard, C., De Wind, R., Drieux, F., Fontaine, J., Parrens, M., Sandrini, J., Fataccioli, V., Delfau-Larue, M.-H., ... De Leval, L. (2023). Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome. Haematologica, 108, 181 - 195. doi:10.3324/haematol.2022.281226
Peer Reviewed verified by ORBi

Fornecker, L.-M., Lazarovici, J., Aurer, I., Casasnovas, R.-O., Gac, A.-C., Bonnet, C., Bouabdallah, K., Feugier, P., Specht, L., Molina, L., Touati, M., Borel, C., Stamatoullas, A., Nicolas-Virelizier, E., Pascal, L., Lugtenburg, P., Di Renzo, N., Vander Borght, T., Traverse-Glehen, A., ... LYSA-FIL-EORTC Intergroup. (2023). Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial. Journal of Clinical Oncology, 41, 327 - 335. doi:10.1200/JCO.21.01281
Peer Reviewed verified by ORBi

Nicolae, A., Bouilly, J., Lara, D., Fataccioli, V., Lemonnier, F., Drieux, F., Parrens, M., Robe, C., Poullot, E., Bisig, B., Bossard, C., Letourneau, A., Missiaglia, E., Bonnet, C., Szablewski, V., Traverse-Glehen, A., Delfau-Larue, M.-H., de Leval, L., & Gaulard, P. (August 2022). Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations. Modern Pathology, 35, 1126 - 1136. doi:10.1038/s41379-022-01022-w
Peer Reviewed verified by ORBi

LOVINFOSSE, P., Ferreira, M., WITHOFS, N., JADOUL, A., Derwael, C., Frix, A.-N., GUIOT, J., BERNARD, C., Diep, A. N., Donneau, A.-F., LEJEUNE, M., BONNET, C., Vos, W., Meyer, P., & HUSTINX, R. (19 May 2022). Distinction of lymphoma from sarcoidosis at FDG PET/CT - evaluation of radiomic-feature guided machine learning versus human reader performance. Journal of Nuclear Medicine, 63, 1933-1940. doi:10.2967/jnumed.121.263598
Peer Reviewed verified by ORBi

BONNET, C., Dupuis, J., Tilly, H., Lamy, T., Fruchart, C., le Gouill, S., Thieblemont, C., Morschhauser, F., Casasnovas, O., Bouabdallah, K., Ghesquieres, H., Van Den Neste, E., André, M., Cartron, G., & Salles, G. (30 March 2022). Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group. Cancers, 14, 1761. doi:10.3390/cancers14071761
Peer Reviewed verified by ORBi

Sibon, D., Bisig, B., Bonnet, C., Poullot, E., Bachy, E., Cavalieri, D., Fataccioli, V., Bregnard, C., Drieux, F., Bruneau, J., Lemonnier, F., Dupuy, A., Bossard, C., Parrens, M., Bouabdallah, K., Ketterer, N., Berthod, G., Cairoli, A., Damaj, G., ... De Leval, L. (2022). ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study. Haematologica. doi:10.3324/haematol.2022.281442
Peer Reviewed verified by ORBi

Casasnovas, R.-O., Bouabdallah, R., Brice, P., Lazarovici, J., Ghesquieres, H., Stamatoullas, A., Dupuis, J., Gac, A.-C., Gastinne, T., Joly, B., Bouabdallah, K., Nicolas-Virelizier, E., Feugier, P., Morschhauser, F., Sibon, D., Bonnet, C., Berriolo-Riedinger, A., Edeline, V., Parrens, M., ... Rossi, C. (2022). Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study. Journal of Clinical Oncology, 40, 1091 - 1101. doi:10.1200/JCO.21.01777
Peer Reviewed verified by ORBi

Jullien, M., Tessoulin, B., Ghesquières, H., Oberic, L., Morschhauser, F., Tilly, H., Ribrag, V., Lamy, T., Thieblemont, C., Villemagne, B., Gressin, R., Bouabdallah, K., Haioun, C., Damaj, G., Fornecker, L.-M., Schiano De Colella, J.-M., Feugier, P., Hermine, O., Cartron, G., ... Le Gouill, S. (07 September 2021). Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years. Cancers, 13, 4503. doi:10.3390/cancers13184503
Peer Reviewed verified by ORBi

MAQUET, C., BEGUIN, Y., DE PRIJCK, B., WILLEMS, E., SERVAIS, S., & BONNET, C. (2021). Le lymphome diffus à grandes cellules B : nouveau traitement révolutionnaire par des cellules immunitaires génétiquement modifiées appelées «CAR T cells». Revue Médicale de Liège, 76, 476-481.
Peer reviewed

Oberic L., Peyrade F., Puyade M., BONNET, C., Dartigues-Cuillères P., Fabiani B., Ruminy P., Maisonneuve H., Abraham J., Thieblemont C., Feugier P., Salles G., Bijou F., Pica GM., Damaj G., Haioun C., Casasnovas RO., Farhat H., Le Calloch R., ... Jardin F. (2021). Subcutaneous Rituximab-MiniCHOP compared with subcutaneous Rituximab-MiniCHOP plus Lenalidomide in diffuse large B-Cell lymphoma for patients age 80 years or older. Journal of Clinical Oncology, 39, 1203-1213. doi:10.1200/JCO.20.02666
Peer Reviewed verified by ORBi

Buedts, L., Wlodarska, I., Finalet-Ferreiro, J., Gheysens, O., Dehaspe, L., Tousseyn, T., Fornecker, L.-M., Lazarovici, J., Casasnovas, R.-O., Gac, A.-C., BONNET, C., Bouabdallah, K., Copie-Bergman, C., Fabiani, B., Dierickx, D., Marcelis, L., Vermeesch, J., André, M., & Vandenberghe, P. (2021). The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA. Blood Advances, 5, 1991-2002. doi:10.1182/bloodadvances.2020003039
Peer Reviewed verified by ORBi

Le Gouill, S., Ghesquieres, H., Obéric, L., Morschhauser, F., Tilly, H., Ribrag, V., Lamy, T., Thieblemont, C., Maisonneuve, H. G., Gressin, R., Bouabdallah, K., Haioun, C., Damaj, G., Fornecker, L. M., Bouabdallah, R., Feugier, P., Sibon, D., Cartron, G., BONNET, C., ... Casasnovas, O. (2021). Obinutuzumab versus Rituximab in young patients with advanced DLBCL, a PET-guided and randomized phase 3 study by LYSA. Blood, 137 (17), 2307-2320. doi:10.1182/blood.2020008750
Peer Reviewed verified by ORBi

LEBAS, E., COLLINS, P., BONNET, C., Libon, F., DEZFOULIAN, B., & NIKKELS, A. (2021). Comment je traite… le mycosis fongoïde : à propos du brentuximab védotine, une nouvelle arme thérapeutique. Revue Médicale de Liège, 76 (4), 224-231.
Peer reviewed

RADERMECKER, A., BONNET, C., LUTTERI, L., CHAPELLE, A.-C., PETIGNOT, S., LIEVENS, I., & CAERS, J. (2021). Un cas illustratif de syndrome de POEMS. Revue Médicale de Liège, 76, 156-159.
Peer reviewed

Camus, V., Rossi, C., Sesques, P., Lequesne, J., Tonnelet, D., Haioun, C., Durot, E., Willaume, A., Gauthier, M., Moles-Moreau, M.-P., Antier, C., Lazarovici, J., Monjanel, H., Bernard, S., Tardy, M., Besson, C., Lebras, L., Choquet, S., Le Du, K., ... Tilly, H. (2021). Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study. Blood Advances, 5, 3862-3872. doi:10.1182/bloodadvances.2021004778
Peer Reviewed verified by ORBi

WITHOFS, N., Beguin, Y., COUSIN, F., Tancredi, T., SIMONI, P., Alvarez-Miezentseva, V., DE PRIJCK, B., HAFRAOUI, K., Bonnet, C., Baron, F., Hustinx, R., & Caers, J. (2019). Dual-tracer PET/CT scan after injection of combined [ 18 F]NaF and [ 18 F]FDG outperforms MRI in the detection of myeloma lesions. Hematological Oncology, 37, 193-201. doi:10.1002/hon.2600
Peer Reviewed verified by ORBi

Houot, R., Cartron, G., Bijou, F., de Guibert, S., Salles, G. A., Fruchart, C., Bouabdallah, K., Maerevoet, M., Feugier, P., Le Gouill, S., Tilly, H., Casasnovas, R.-O., Moluçon-Chabrot, C., Van Den Neste, E., Zachee, P., André, M., Bonnet, C., Haioun, C., Van Hoof, A., ... Morschhauser, F. (2019). Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study. Leukemia, 33, 776-780. doi:10.1038/s41375-018-0282-y
Peer Reviewed verified by ORBi

Morschhauser F., Le Gouill S., Feugier P., Bailly S., Nicolas-Virelizier E., Bijou F., Salles GA., Tilly H., Fruchart C., Van Eygen K., Snauwaert S., BONNET, C., Haioun C., Thieblemont C., Bouabdallah R., Wu KL., Canioni D., Meignin V., Cartron G., & Houot R. (2019). Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study. The Lancet Haematology, 6, 429-e437. doi:10.1016/S2352-3026(19)30089-4
Peer Reviewed verified by ORBi

Cabannes-Hamy, A., Peyrade, F., Jardin, F., Emile, J., Delwail, V., Mounier, N., Haioun, C., Perrot, A., Fitoussi, O., Lara, D., Delarue, R., André, M., Offner, F., Gherquières, H., Pascal, L., Soussain, C., Lazarovici, J., Schiano, J., Gaulard, P., ... BONNET, C. (Other coll.). (2018). Central nervous system relapse in patients over 80 years with diffuse large B-cell lymphoma: an analysis of two LYSA studies. Cancer Medicine. doi:10.1002/cam4.1139
Peer Reviewed verified by ORBi

FOSSARD, G., BROUSSAIS, F., COELHO, I., BAILLY, S., NICOLAS-VIRELIZIER, E., TOUSSAINT, E., LANCESSEUR, C., LE COTTEREAU, A., EL-GALALY, T., BECKER, S., PETERSON, L., Bonnet, C., PRIOR, J., TILLY, H., HUTCHINGS, M., CASASNOVAS, O., & MEIGNAN, M. (2018). Predictive value of PET response combined with baseline metabolic tumor volume in peripheral T-cell lymphoma patients. European Journal of Nuclear Medicine, 59. doi:10.2967/jnumed.117.193946
Peer Reviewed verified by ORBi

Fossard, G., Broussais, F., Coelho, I., Bailly, S., Nicolas-Virelizier, E., Toussaint, E., Lancesseur, C., Le Bras, F., WILLEMS, E., Tchernonog, E., Chalopin, T., Delarue, R., Gressin, R., Chauchet, A., Gyan, E., Cartron, G., Bonnet, C., BOUABDALLAH, R., SALLES, G., & BACHY, E. (2018). Role of up-front autologous stem cell transplantation in peripheral T-cell lymphoma for patients in response after induction: An analysis of patients from LYSA centers. Annals of Oncology, 29, 715-723. doi:10.1093/annonc/mdx787
Peer Reviewed verified by ORBi

Vergote, V., Janssens, A., André, M., Bonnet, C., Van Hende, V., Van Den Neste, E., Van Eygen, K., Maerevoet, M., Pranger, D., Schroyens, W., Debussche, S., Maertens, V., Beel, K., Lemmens, J., Caron, C., Delrieu, V., Van Den Broeck, I., Vanstraelen, G., Jacquy, C., ... Van Hoof, A. (22 February 2017). Results from the Belgian mantle cell lymphoma registry. Acta Clinica Belgica, 38, 1-7. doi:10.1080/17843286.2017.1293328
Peer Reviewed verified by ORBi

WITHOFS, N., COUSIN, F., DE PRIJCK, B., Bonnet, C., Hustinx, R., Gambhir, S. S., Beguin, Y., & Caers, J. (2017). A First Report on [(18)F]FPRGD2 PET/CT Imaging in Multiple Myeloma. Contrast Media and Molecular Imaging, 2017, 6162845. doi:10.1155/2017/6162845
Peer Reviewed verified by ORBi

Bron, D., Aurer, I., Bonnet, C., Caballero, D., Falandry, C., Kimby, E., Soubeyran, P., Zucca, E., Bosly, A., Coiffier, B., & André, M. (2017). Unmet needs in the scientific approach to older patients with lymphoma. Haematologica, 102 (6), 972-975. doi:10.3324/haematol.2017.167619
Peer Reviewed verified by ORBi

SID, S., Baron, F., WILLEMS, E., Caers, J., Bonnet, C., DE PRIJCK, B., LEJEUNE, M., HAFRAOUI, K., Servais, S., JASPERS, A., & Beguin, Y. (November 2016). Hematologic recovery after autologus stem cell transplantation in multiple myeloma: a single center experience of 225 patients [Paper presentation]. 16ème Congrès commun de la SFGM-TC & 8ème de la SFBCT, Liège, Belgium.

Vallois, D., Dobay, M. P. D., Morin, R. D., Lemonnier, F., Missiaglia, E., Juilland, M., Iwaszkiewicz, J., Fataccioli, V., Bisig, B., Roberti, A., Grewal, J., Bruneau, J., Fabiani, B., Martin, A., Bonnet, C., Michielin, O., Jais, J.-P., Figeac, M., Bernard, O. A., ... de Leval, L. (15 September 2016). Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell–derived lymphomas. Blood, 128, 1490-1502. doi:10.1182/blood-2016-02-698977
Peer Reviewed verified by ORBi

WITHOFS, N., COUSIN, F., TANCREDI, T., SIMONI, P., DE PRIJCK, B., HAFRAOUI, K., BONNET, C., HUSTINX, R., BEGUIN, Y., & CAERS, J. (14 June 2016). Comparison of combined whole-body 18F-NAF and 18F-FDG PET/CT versus MRI for the detection of myeloma lesions [Paper presentation]. SNMMI 2016 Annual Meeting.

Springael, C., Delrieu, V., Wu, K. L., Schroyens, W., Bonnet, C., Bron, D., & Janssens, A. (June 2016). BHS guidelines for the treatment of large granular lymphocyte and cronic prolymphocytic leukaemias. Belgian Journal of Hematology, 7, 103-111.
Peer Reviewed verified by ORBi

Bonnet, C. (May 2016). La prise en charge du lymphome chez le patient âgé [Paper presentation]. Axis congress center, Mont-St-Guibert, Belgium.

Cottereau, A. S., Becker, S., Broussais, F., Casasnovas, O., Kanoun, S., Roques, M., Charrier, N., Bertrand, S., Delarue, R., Bonnet, C., Hustinx, R., Gaulard, P., de Leval, L., Vera, P., Itti, E., Mounier, N., Haioun, C., Tilly, H., & Meignan, M. (April 2016). Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)†. Annals of Oncology, 27, 719-724. doi:10.1093/annonc/mdw011
Peer Reviewed verified by ORBi

Pilorge, S., Harel, S., Ribrag, V., Larousserie, F., Willems, L., Franchi, P., Legoff, M., Biau, D., Anract, P., Roux, C., Blanc-Autran, E., Delarue, R., Gisselbrecht, C., Ketterer, N., Recher, C., Bonnet, C., Peyrade, F., Haioun, C., Tilly, H., ... Tamburini, J. (2016). Primary bone diffuse large B-cell lymphoma: a retrospective evaluation on 76 cases from French institutional and LYSA studies. Leukemia and Lymphoma, 57, 2820-2826. doi:10.1080/10428194.2016.1177180
Peer Reviewed verified by ORBi

BONNET, C., & BOSLY, A. (October 2015). Highlights of the 13th International Conference on Malignant Lymphoma. Belgian Journal of Hematology, 6 (4), 173-178.
Peer Reviewed verified by ORBi

VAN HENDE, V., BRON, D., VAN DEN NESTE, E., BONNET, C., ANDRE, M., VAN HOOF, A., DIERICKX, D., VERHOEF, G., TOUSSEYN, T., JANSSENS, A., DE WILDE, V., WU, K. L., & HEIMANN, P. (October 2015). Waldenström's macroglobulinaemia: Belgian Hematology Society guidelines. Belgian Journal of Hematology, 6 (4), 142-151.
Peer Reviewed verified by ORBi

JASPERS, A., Baron, F., SERVAIS, S., LEJEUNE, M., WILLEMS, E., SEIDEL, L., HAFRAOUI, K., Bonnet, C., & Beguin, Y. (September 2015). Erythropoietin therapy after allogeneic hematopoietic cell transplantation has no impact on long-term survival. American Journal of Hematology, 90 (9), 197-199. doi:10.1002/ajh.24100
Peer Reviewed verified by ORBi

JASPERS, A., Baron, F., Maertens, J., DE PRIJCK, B., Schots, R., Bonnet, C., HAFRAOUI, K., WILLEMS, E., SERVAIS, S., FILLET, G., & Beguin, Y. (July 2015). Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation [letter to the editor]. American Journal of Hematology, 90 (7), 133-4. doi:10.1002/ajh.24013
Peer Reviewed verified by ORBi

BONNET, C., Janssens, A., Wu, K., Schroyens, W., Van Hende, V., Heimann, P., Tousseyn, T., André, M., Bron, D., Van Hoof, A., Verhoef, G., DE PRIJCK, B., Beguin, Y., & Dierickx, D. (2015). BHS guidelines for the treatment of Burkitt lymphoma. Belgian Journal of Hematology, 6 (2), 61-69.
Peer Reviewed verified by ORBi

SID, S., Dugauquier, C., DE PRIJCK, B., BONNET, C., & Beguin, Y. (2015). Haemolytic crisis induced by rasburicase administration revealing G-6-PD deficiency. Belgian Journal of Hematology, 6 (2), 74-78.
Peer Reviewed verified by ORBi

FOGUENNE, J., SIMUL, M., KEUTGENS, A., TASSIN, F., Bonnet, C., BEGUIN, Y., JAMAR, M., LAMBERT, F., & GOTHOT, A. (2015). Multiparameter flow cytometric analysis of composite lymphoma: case report of a mantle cell lymphoma associated with a B-cell chronic lymphocytic leukemia and an aberrant T cell subset. Belgian Journal of Hematology.
Peer Reviewed verified by ORBi

Bonnet, C., LEJEUNE, M., VAN KEMSEKE, C., Bron, D., & Beguin, Y. (2015). Prise en charge actuelle du lymphome de la zone marginale. Revue Médicale Suisse, 11, 1549-1556.
Peer Reviewed verified by ORBi

JASPERS, A., BARON, F., MAERTENS, J., DE PRIJCK, B., SCHOTS, H., BONNET, C., HAFRAOUI, K., WILLEMS, E., SERVAIS, S., FILLET, G., & BEGUIN, Y. (December 2014). Long-term safety follow-up of a rendomized trial of Darbepoetin Alpha and intravenous iron following autologous hematopoietic cell transplantation. Blood, 124 (21), 3948.
Peer Reviewed verified by ORBi

MOERMANS, C., BONNET, C., WILLEMS, E., Baron, F., NGUYEN DANG, D., HENKET, M., Sele, J., CORHAY, J.-L., Beguin, Y., & Louis, R. (November 2014). Sputum cytokines levels in patients undergoing hematopoietic SCT (HSCT) and comparison with healthy subjects and COPD: a pilot study. Bone Marrow Transplantation, 49 (11), 1382-1388. doi:10.1038/bmt.2014.164
Peer Reviewed verified by ORBi

MOURIN, E., VAN HOOF, A., BOSLY, A., Bonnet, C., DE WILDE, V., DOYEN, C., HERMANS, C., JANSSENS, A., MICHAUX, L., SCHROYENS, W., SONET, A., VAN DEN NESTE, E., VERHOEF, G., ZACHEE, P., & ANDRE, M. (September 2014). Treatment of mantle cell lymphomas: recommendations of the Belgian Hematological Society. Belgian Journal of Hematology, 5, 89.
Peer Reviewed verified by ORBi

BRON, D., VAN DEN NESTE, E., KENTOS, A., OFFNER, F., SCHROYENS, W., Bonnet, C., VAN HOOF, A., VERHOEF, G., & JANSSENS, A. (March 2014). BHS guidelines for the treatment of marginal zone lymphomas. Belgian Journal of Hematology, 5, 12-17.
Peer Reviewed verified by ORBi

JASPERS, A., Baron, F., WILLEMS, E., HAFRAOUI, K., Bonnet, C., & Beguin, Y. (2014). Long-term survival in patients receiving rhEPO following allogeneic hematopoietic cell transplantation. Belgian Journal of Hematology, 14.
Peer Reviewed verified by ORBi

SID, S., Dugauquier, D., DE PRIJCK, B., Bonnet, C., & Beguin, Y. (2014). Hemolytic crisis induced by rasburicase administration revealing G-6-PD deficiency. Belgian Journal of Hematology, 17-18.
Peer Reviewed verified by ORBi

André, M., DE PRIJCK, B., Kentos, A., Van Hoof, A., Bonnet, C., Sonet, A., Maerevoet, M., Van Den Neste, E., Bosly, A., & Mounier, N. (2014). ABVD (8 cycles) vs. BEACOPP (4 escalated cycles => 4 baseline) in stage III - IV low risk Hodgkin Lymphoma (IPS 0-2): final results of LYSA H34 trial. Belgian Journal of Hematology, 12.
Peer Reviewed verified by ORBi

JASPERS, A., Baron, F., WILLEMS, E., HAFRAOUI, K., Vanstraelen, G., Bonnet, C., & Beguin, Y. (2014). Erythropoietin therapy after allogeneic hematopoietic cell transplantation : a prospective randomized trial. Blood, 124, 33-41. doi:10.1182/blood-2014-01-546333
Peer Reviewed verified by ORBi

SOMJA, J., Bisig, B., de Leval, L., Bonnet, C., HERENS, C., & Siebert, R. (2014). Peripheral T-cell lymphoma with t(6;14)(p25;q11.2) translocation presenting with massive splenomegaly. Virchows Archiv. doi:10.1007/s00428-014-1560-3
Peer Reviewed verified by ORBi

Bonnet, C., MENTEN, C., LAMBERT, F., Gothot, A., Baron, F., CAERS, J., HERENS, C., & Beguin, Y. (25 January 2013). Simultaneous diagnosis of CLL and CML in a single patient with evidence for two different cell clones [Poster presentation]. BHS, General Annual Meeting.

Van Obbergh, F., Van Hoof, A., Verhoef, G., Dierickx, D., De Wilde, V., Offner, F., Bron, D., Sonet, A., André, M., Janssens, A., Bonnet, C., DE PRIJCK, B., Zachée, P., Kentos, A., Schroyens, W., & Van Den Neste, E. (2013). Treatment of peripheral T-cell lymphomas: recommendations of the Belgian Hematological Society (BHS). Belgian Journal of Hematology, 4 (3), 90-101.
Peer Reviewed verified by ORBi

Ketterer, N., Coiffier, B. B., Thieblemont, C., Fermé, C., Brière, J. F., Casasnovas, O., Bologna, S., Christian, B., Connerotte, T., Récher, C., Bordessoule, D., Fruchart, C., Delarue, R., Bonnet, C., Morschhauser, F. A., Anglaret, B., Soussain, C., Fabiani, B., Tilly, H., & Haioun, C. (2013). Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B). Annals of Oncology, 24/n°4, 1032-1037. doi:10.1093/annonc/mds600
Peer Reviewed verified by ORBi

BEGUIN, Y., Maertens, J., DE PRIJCK, B., Schots, R., Seidel, L., BONNET, C., HAFRAOUI, K., WILLEMS, E., Vanstraelen, G., SERVAIS, S., JASPERS, A., FILLET, G., & BARON, F. (2013). Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation : A prospective multicenter randomized trial. American Journal of Hematology, 88, 990-996. doi:10.1002/ajh.23552
Peer Reviewed verified by ORBi

Moermans, C., Poulet, C., HENKET, M., Bonnet, C., WILLEMS, E., Baron, F., Beguin, Y., & Louis, R. (2013). Lung function and airway inflammation monitoring after hematopoietic stem cell transplantation. Respiratory Medicine, 107, 2071-2080. doi:10.1016/j.rmed.2013.10.013
Peer Reviewed verified by ORBi

Bisig, B., de Reyniès, A., Bonnet, C., Sujobert, P., Rickman, D. S., Marafioti, T., Delsol, G., Lamant, L., Gaulard, P., & de Leval, L. (2013). CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features. Haematologica, 98/n°8, 1250-1258. doi:10.3324/haematol.2012.081935
Peer Reviewed verified by ORBi

JASPERS, A., Baron, F., WILLEMS, E., HAFRAOUI, K., Vanstraelen, G., Bonnet, C., & Beguin, Y. (2013). Erythropoietin therapy after allogeneic hematopoietic cell transplantation : a prospective randomised trial. Belgian Journal of Hematology, 16.
Peer Reviewed verified by ORBi

Bossard, C., Dobay, M. P., Lamant, L., Missiglia, E., Parrens, M., Martin, A., Tournillac, O., Haioun, C., Bonnet, C., Berger, F., Bouchind'homme, B., Delarue, R., Rousset, T., Thiebault, S., Picquenot, J., Fabiani, B., Delorenzi, M., Gaulard, P., & de Leval, L. (2013). Correlation between RNA and protein levels in a large european series from the LYSA. Hematological Oncology, 31 Suppl.1, 146-147.
Peer Reviewed verified by ORBi

Verhoef, G., Schroyens, W., Bron, D., Bonnet, C., De Wilde, V., Van Hoof, A., Janssens, A., Dierickx, D., André, M., & Van Den Neste, E. (2013). Guidelines for newly diagnosed diffuse large B-cell lymphoma (DLBCL) and relapsed DLBCL. Belgian Journal of Hematology, 4 (2), 51-57.
Peer Reviewed verified by ORBi

Debussche, S., Van Hoof, A., Sonet, A., Bonnet, C., Janssens, A., Verhoef, G., Dierickx, D., De Wilde, V., Bron, D., Schroyens, W., Van Den Neste, E., & Offner, F. (2012). Guidelines of the Belgian Hematological Society for newly diagnosed and relapsed follicular lymphoma 2012. Belgian Journal of Hematology, 3 (2), 41-50.
Peer Reviewed verified by ORBi

de Leval, L., BONNET, C., Copie-Bergman, C., SEIDEL, L., Baia, M., Brière, J., Molina, T., Fabiani, B., Petrella, T., Bosq, J., Gisselbrecht, C., Siebert, R., Tilly, H., Haioun, C., Fillet, G., & Gaulard, P. (2012). Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study. Annals of Oncology. doi:10.1093/annonc/mds150
Peer Reviewed verified by ORBi

de Leval, L., Bonnet, C., Copie-Bergman, C., Seidel, L., Baia, M., Brière, J., Molina, T. J., Fabiani, B., Petrella, T., Bosq, J., Gisselbrecht, C., Siebert, R., Tilly, H., Haioun, C., Fillet, G., & Gaulard, P. (2012). Diffuse large B-cell lymphoma of Waldeyer's ring has distinc clinicopathologic features: a GELA study. Annals of Oncology, 23(12), 3143-3151.
Peer Reviewed verified by ORBi

Bonnet, C., DE PRIJCK, B., LEJEUNE, M., FASSOTTE, M.-F., Van Den Neste, E., & Beguin, Y. (2012). Prise en charge du lymphome B diffus à grandes cellules en 2012. Revue Médicale Suisse, 8, 1582-90.
Peer Reviewed verified by ORBi

CAERS, J., BONNET, C., GRAUX, C., DE PRIJCK, B., & BEGUIN, Y. (2011). Prise en charge actuelle des syndromes myélodysplasiques. Revue Médicale Suisse, 7, 1634-1643.
Peer Reviewed verified by ORBi

Bonnet, C., CAERS, J., DE PRIJCK, B., HAFRAOUI, K., & Beguin, Y. (2011). Lymphome du manteau : prise en charge 2011. Revue Médicale Suisse, 7, 1644-1649.
Peer Reviewed verified by ORBi

Récher, C., Coiffier, B., Haioun, C., Molina, T. J., Fermé, C., Casasnovas, O., Thièblement, C., Bosly, A., Laurent, G., Morschhauser, F., Ghesquières, H., Jardin, F., Bologna, S., Fruchart, C., Corront, B., Gabarre, J., Bonnet, C., Janvier, M., Canioni, D., ... Tilly, H. (2011). Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial. The Lancet, 378(9806), 1858-1867. doi:10.1016/S0140-6736(11)61040-4
Peer Reviewed verified by ORBi

Bosly, A., Delarue, R., Bonnet, C., Van Hoof, A., Van Den Neste, E., Maerevoel, M., Zachée, P., Bron, D., Mathieux, V., Fournier, M., Molina, T., Haioun, C., & Tilly, H. (2010). R-CHOP14 compared to R-CHOP21 in elderly patients with diffuse large B-ell lymphoma: results of the interim analysis of the LNH03- GELA study [Poster presentation]. 25th General Meeting of the Belgian Hematological Society.

Jaspers, A., Baron, F., Bonnet, C., De Prijck, B., Fassotte, M.-F., & Beguin, Y. (2010). Le lymphome du manteau. Revue Médicale de Liège, 65, 171-176.
Peer reviewed

Bonnet, C., Beguin, Y., De Prijck, B., de Leval, L., & Fillet, G. (2009). Traitements actuels du lymphome folliculaire. Revue Médicale Suisse, 5, 1663-7.
Peer Reviewed verified by ORBi

Bonnet, C., Beguin, Y., De Prijck, B., Witvrouw, N., Hustinx, R., & Fillet, G. (2009). Les anticorps monoclonaux en hématologie en 2009. Revue Médicale de Liège, 64, 268-273.
Peer reviewed

Beguin, Y., Maertens, J., DE PRIJCK, B., Schots, R., Frère, P., Bonnet, C., HAFRAOUI, K., WILLEMS, E., Vanstraelen, G., LEJEUNE, M., SERVAIS, S., THeunissen, K., Fillet, G., & Baron, F. (2009). A prospective randomized multicenter trial of darbepoetin-alfa and I.V. iron administration after autologous hematopoietic stem cell transplantation [Poster presentation]. 24th General Meeting of the Belgian Hematological Society, Oostende, Belgium.

Willems, E.* , Baron, F.* , Baudoux, E., Wanten, N., Seidel, L., Vanbellinghen, J.-F., Herens, C., Gothot, A., Frere, P., Bonnet, C., Hafraoui, K., Vanstraelen, G., Fillet, G., & Beguin, Y. (2009). Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial. Leukemia, 23 (3), 608-10. doi:10.1038/leu.2008.248
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

de Leval, L., Bonnet, C., Brière, J., Molina, T., Petrella, T., Bosq, J., Falini, B., Gisselbrecht, C., Reyes, F., Fillet, G., & Gaulard, P. (2008). Diffuse large B-cell lymphoma (DLBCL) of the waldeyer'ring (WR) frequently have a GC-like phenotype: a clinico-pathological study of 209 patients from the groupe d'étude des lymphomes de l'adulte (GELA). Annals of Oncology, 13(suppl 4), 366.
Peer Reviewed verified by ORBi

Bonnet, C. (2007). Contribution à l'étude des lymphomes: Aspects pronostiques et thérapeutiques [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/160761

Bonnet, C., Fillet, G., Mounier, N., Ganem, G., Molina, T. J., Thieblemont, C., Ferme, C., Quesnel, B., Brassiene, C., Gisselbrecht, C., Tilly, H., & Reyes, F. (01 March 2007). CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: A study by the Groupe d'Etude des Lymphomes de I'Adulte. Journal of Clinical Oncology, 25 (7), 787-792. doi:10.1200/JCO.2006.07.0722
Peer Reviewed verified by ORBi

de Leval, L., Bonnet, C., Copie-Bergman, C., Seidel, L., Baia, M., Brière, J., Molina, T., Fabiani, B., Falini, B., Gisselbrecht, C., Thilly, H., Albert, A., Fillet, G., & Gaulard, P. (2007). Diffuse large B-cell lymphomas of the waldeyer's ring frequently have a germinal center-like phenotype: a clinico-pathological study of 209 patients from the groupe d'étude des lymphomes de l'adulte (GELA). Annual Meeting Abstracts, 110, 1561.
Peer reviewed

De Prijck, B., Baron, F., Beguin, Y., Bonnet, C., Willems, E., & Fillet, G. (2007). Actualités thérapeutiques en hématologie. Revue Médicale de Liège, 62 (5-6), 384-90.
Peer reviewed

Bonnet, C., & Fillet, G. (2007). How can we determine the role of radiotherapy in the treatment of localized aggressive non Hodgkin's lymphoma? Journal of Clinical Oncology, 25/n°19, 2857-2858.
Peer Reviewed verified by ORBi

de Leval, L., Bonnet, C., Copie-Bergmann, C., Seidel, L., Brière, J., Molina, T., Fabiani, B., Brunangelo, F., Gisselbrecht, C., Thilly, H., Albert, A., Fillet, G., & Gaulard, P. (2007). Diffuse Large B-cell Lymphomas of the waldeyer's ring frequently have a germinal center-like phenotype: a clinico-pathological study of 209 patients from the groupe d'étude des lymphomes de l'adulte (GELA). Blood.
Peer Reviewed verified by ORBi

Trimeche, M., Bonnet, C., Korbi, S., Boniver, J., & de Leval, L. (2007). Association between Epstein-Barr virus and Hodgkin's lymphoma in Belgium: A pathological and virological study. Leukemia and Lymphoma, 48 (7), 1323-1331. doi:10.1080/10428190701411177
Peer Reviewed verified by ORBi

Bonnet, C., Beguin, Y., Fassotte, M.-F., Seidel, L., Luyckx, F., & Fillet, G. (2007). Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma. European Journal of Haematology, 78 (5), 399-404. doi:10.1111/j.1600-0609.2007.00843.x
Peer Reviewed verified by ORBi

WILLEMS, E., CASTERMANS, E., Baron, F., BAUDOUX, E., Wanten, N., Bonnet, C., HAFRAOUI, K., Frère, P., Fillet, G., & Beguin, Y. (2006). Nonmyeloablative stem cell transplantation with CD8-depleted or unmalipulated peripheral blood stem cells: a prospective randomized trial [Paper presentation]. 21st General Meeting of the Belgian Hematological Society.

Bonnet, C., Fillet, G., Mounier, N., Ganem, G., Molina, T., Thieblemont, C., Ferme, C., Quesnel, B., Martin, C., Gisselbrecht, C., Tilly, H., & Reyes, F. (2006). No role for chemoradiotherapy compared with chemotherapy alone in elderly patients with localized low risk aggressive lymphoma: final results of the LNH93-4 GELA study [Poster presentation]. 21st General Meeting of the Belgian Hematological Society.

Bonnet, C., Fillet, G., Mounier, N., Ganem, G., Molina, T., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Gisselbrecht, C., Tilly, H., & Reyes, F. (January 2006). No role for chemoradiotherapy when compared with chemotherapy alone in elderly patients with localized low risk aggressie lymphoma: final results of the LNH 93-4 GELA Study [Poster presentation]. 21st General Meeting of the Belgian Hematological Society.

Bonnet, C., Beguin, Y., FASSOTTE, M.-F., & Fillet, G. (2006). Limited usefulness of CA 125 measurement in the management of hodgkin's and non-hodgkin's lymphomas [Poster presentation]. 21st General Meeting of the Belgian Hematological Society.

Vanstraelen, G., Baron, F., Willems, E., Bonnet, C., Hafraoui, K., Frere, P., Fillet, G., & Beguin, Y. (2006). Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response. Experimental Hematology, 34 (7), 841-50. doi:10.1016/j.exphem.2006.04.012
Peer reviewed

Frere, P., Baron, F., Bonnet, C., Hafraoui, K., Pereira-Martins, M., Willems, E., Fillet, G., & Beguin, Y. (2006). Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen. Bone Marrow Transplantation, 37 (4), 411-8. doi:10.1038/sj.bmt.1705255
Peer Reviewed verified by ORBi

Fillet, G., Bonnet, C., Mounier, N., Ganem, G., Molina, T., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Gisselbrecht, C., Tilly, H., & Reyes, F. (2005). No role for chemoradiotherapy when compared with chemotherapy alone in elderly patients with localized low risk aggressive lymphoma: final results of the LNH93-4 GELA study. Blood, 106 (15).
Peer Reviewed verified by ORBi

WILLEMS, E., CASTERMANS, E., Baron, F., BAUDOUX, E., Wanten, N., Bonnet, C., HAFRAOUI, K., Frère, P., Fillet, G., & Beguin, Y. (2005). Nonmyeloablative stem cell transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a prospective randomized trial. Blood, 106 (1075).
Peer Reviewed verified by ORBi

Fillet, G., Bonnet, C., Mounier, N., Ganem, N., Molina, T., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Gisselbrecht, C., Tilly, H., & Reyes. (2005). No advantage of chemoradiotherapy over chemotherapy alone in elderly patients with localized low risk aggressive lymphoma: results of the LNH93-4 GELA study. Annals of Oncology, 16 (suppl 5).
Peer Reviewed verified by ORBi

Gillain, S., Gennigens, C., Sautois, B., Polus, M., Bonnet, C., Fillet, G., & Jerusalem, G. (2004). Traitement du cancer du sein chez la personne âgée. Revue Médicale Suisse, 62, 1618-21.
Peer Reviewed verified by ORBi

Bonnet, C., Fillet, G., Bosly, A., Van Hoof, A., Offner, F., Van Den Neste, E., DE PRIJCK, B., Deflandre, A., Gisselbrecht, C., & Reyes, F. (2003). Radiotherapy is unnecessary in elderly patients with localized aggressive non hodgkin's lymphoma: results of the LNH 93-4 study [Paper presentation]. 18th General Meeting of the Belgian Hematological Society, Brussels, Belgium.

Bonnet, C., Fillet, G., Mounier, N., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Blanc, M., Conroy, T., Penny, A., Petrella, T., & Reyes, F. (2002). Radiotherapy is unnecessary in elderly patients with localized agressive non Hodgkin's lymphoma: results of the LNH 93-4 study. Annals of Oncology, 13 (suppl 2), 27.
Peer Reviewed verified by ORBi

Bonnet, C., Fillet, G., Mounier, N., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Blanc, M., Conroy, T., Penny, A. M., Petrella, T., & Reyes, F. (2002). Radiotherapy is unnecessary in elderly patients with localized agressive non Hodgkin's lymphoma: results of the LNH 93-4 study. Blood, 100 (11), 92.
Peer Reviewed verified by ORBi

Bonnet, C., Jerusalem, G., Bours, V., & Fillet, G. (2000). Approches thérapeutiques du cancer ovarien. Médecine et Hygiène, 58, 1625-1628.
Peer Reviewed verified by ORBi

Malgrange, B., Rogister, B., LEFEBVRE, P., Mazy-Servais, C., Welcher, A. A., Bonnet, C., Hsu, R. Y., Rigo, J.-M., Van De Water, T. R., & Moonen, G. (August 1998). Expression of Growth Factors and Their Receptors in the Postnatal Rat Cochlea. Neurochemical Research, 23 (8), 1133-8. doi:10.1023/A:1020724506337
Peer Reviewed verified by ORBi

Malgrange, B., LEFEBVRE, P., van de Water, T. R., Bonnet, C., Monville, F., Rigo, J.-M., Staecker, H., & Moonen, G. (1998). In vitro ototoxicity of aminoglycosides and platin derivatives. A semi-automatic assay for sensory hair cell damage in explanted rat organ of corti. Toxicology in Vitro, 12 (6), 705-714. doi:10.1016/S0887-2333(98)00048-4
Peer Reviewed verified by ORBi

Malgrange, B., LEFEBVRE, P., Rigo, J. M., Rogister, B., BELACHEW, S., Coucke, P., Bonnet, C., Van De Water, T. R., & Moonen, G. (1997). Effect of neuropeptides on cultured postnatal auditory neurons [Paper presentation]. 34th Workshop on Inner Ear Biology.

Malgrange, B., LEFEBVRE, P., Rogister, B., Mazy-Servais, C., Bonnet, C., Van De Water, T. R., & Moonen, G. (1997). Expression of growth factors and their receptors in various compartments of the postnatal cochlea [Paper presentation]. 10th Meeting ARO.

Rogister, B., Mazy-Servais, C., Leprince, P., Schils, F., Bonnet, C., & Moonen, G. (1996). Molecular cloning of mouse AstaC, a brain protein which is upregulated during development [Paper presentation]. 1st annual Meeting on Belgian Society for Neuroscience.

Contact ORBi